Editor of Patient Care Online.
Investigational Drug Reduces Lp(a) in High-Risk Adults: Daily Dose
Your daily dose of the clinical news you may have missed.
Antiobesity Medications May Help Lower Alcohol Use, New Study Suggests
In a study of adults enrolled in a telehealth weight management program, 45% decreased their alcohol use after taking antiobesity medication.
Awareness of Lung Cancer Screening Remains Low in US: Daily Dose
New Review Highlights Need to Address Sleep Disturbances in Patients with Dementia
Review authors emphasized the need for a more comprehensive approach to dementia management.
New Trial Backs Intensive Blood Pressure Target for Adults with T2D: Daily Dose
Pandemic Medical Misinformation Has Not Prompted Disciplinary Action: Daily Dose
Long-Term Study Provides Insights into Cognitive Aging: Daily Dose
CDC Releases Annual STI Report: Daily Dose
Amgen Reports Promising Phase 2 Data on MariTide for Obesity, Type 2 Diabetes Management
The investigational weight loss drug showed substantial weight loss among people with obesity or overweight with or without T2D without plateaus.
USPSTF Reaffirms Syphilis Screening for Pregnant Individuals Amid Rising Congenital Syphilis Rates
Comments on the draft recommendation can be submitted through December 23, 2024.
Sex-Specific Dementia Risk in Older Adults with OSA: Daily Dose
GLP-1RAs, SGLT2is Cut Risk of Future MI, Stroke in Survivors: Daily Dose
US Trends in Obesity-Related Ischemic Heart Disease Mortality: Daily Dose
Sharp Rise in Early-Onset Colorectal Cancer Mortality Among Young US Adults: Daily Dose
New UTI Guideline Offers Treatment Clarity, but Reveals Pressing Gaps in Research
The recommendations from WikiGuidelines are the first for UTI prevention, diagnosis, and management in over a decade.
Metabolic Bariatric Surgery Takes a Backseat as GLP-1RA Use Rises: Daily Dose
ECLIPSE Trial of Cell-Free DNA Blood-Based CRC Screening Test: Expert Overview
William Grady, MD, coauthor of the ECLIPSE clinical trial, discusses the study's rationale, methods, and key findings.
The Liver Meeting 2024: Bausch Health Presents Phase 3 Study Design for Investigational Rifaximin Formulation to Delay OHE
The RED-C clinical trial program highlights the promising potential of the rifaximin soluble solid dispersion immediate-release tablets for delaying early HE-related decompensation.
Aprocitentan Now Available in the US for Treatment-Resistant Hypertension
Aprocitentan is the first-and-only dual endothelin receptor antagonist approved for the treatment of systemic hypertension.
FDA Accepts Dupilumab sBLA for Review for Treatment of Chronic Spontaneous Urticaria
The target action date for the FDA decision is April 18, 2025, according to Sanofi and Regeneron.
Semaglutide 2.4 mg Cuts Hospitalization Risk in CVD, Obesity: Daily Dose
7 Questions on US STI Trends
The CDC just released its annual STD surveillance report. Are you caught up on the latest trends? Try your hand at these 7 questions to find out.
GLP-1RAs Cut Early Colorectal Cancer Risk in Adults with T2D: Daily Dose
STI Epidemic in US Shows Signs of Slowing, According to New CDC Report
More than 2.4 million STIs were reported in the US in 2023 — a 1.8% decrease from 2022, according to the CDC's annual STI report.
Adjusted Donanemab Dosing Lowers ARIA-E Risk in Early Alzheimer Disease: Daily Dose
FDA Lifts Clinical Hold on Novavax’s COVID-19-Influenza Combination Vaccine
The FDA cleared Novavax to start enrolling the planned phase 3 trial after a safety concern was found to be unrelated to the combination vaccine.
Patient Perspectives on Colonoscopies: Daily Dose
November Issue of Patient Care Online Digital Edition is Now Live
Find details on the surge in US pertussis cases, the first self-administered flu vaccine, and study findings underscoring the evolving nature of long COVID.
Respiratory Virus Season 2024-2025: Expert Insights to Help Primary Care Prepare
Insights on how to manage the "triple threat" of flu, RSV, and COVID-19 this season.
Dupilumab Effective for Severe Atopic Dermatitis at 5 Years: Daily Dose
